PRF1 and cancer: These effector T cells from PBMCs treated with CD3 and CD28 antibodies could secrete IFN-γ and TNF-α to act as cytotoxic cytokines together with granzyme B and perforin to initiate apoptosis in tumor cells, thereby killing cancer cells [27, 28].